Beta-2-microglobulin excretion: An indicator of long term nephrotoxicity during cis-platinum treatment?
- 1 April 1985
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 14 (3) , 247-249
- https://doi.org/10.1007/bf00258126
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinomaCancer, 1983
- The leakage of plasma albumin across small vessel walls during bleomycin treatmentEuropean Journal of Cancer and Clinical Oncology, 1983
- 51Cr‐EDTA clearance determined by one plasma sampleClinical Physiology and Functional Imaging, 1981
- Immunochemical Studies of Human β2‐MicroglobulinAllergy, 1980
- Comparison of methods of evaluating nephrotoxicity of cis-platinumClinical Pharmacology & Therapeutics, 1980
- Beta‐2‐microglobulin review: Its relevance in clinical oncologyMedical and Pediatric Oncology, 1980
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979
- Long term effect of Cis-Diamminedichloride platinum (CDDP) on renal function and structure in manCancer, 1978
- Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular CancerAnnals of Internal Medicine, 1977
- Platinum nephrotoxicityCancer, 1974